| pubmed-article:7977167 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C0009392 | lld:lifeskim |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C1545588 | lld:lifeskim |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:7977167 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:7977167 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:7977167 | pubmed:dateCreated | 1994-12-21 | lld:pubmed |
| pubmed-article:7977167 | pubmed:abstractText | The administration of granulocyte-monocyte colony stimulating factor (GM-CSF) should allow an increase in the doses of chemotherapy for patients with advanced cancers of the head and neck. | lld:pubmed |
| pubmed-article:7977167 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7977167 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977167 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7977167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7977167 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7977167 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:7977167 | pubmed:issn | 0277-3732 | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:RossiLL | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:BenassiGG | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:RossiSS | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:MerlanoMM | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:CavallariMM | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:SguottiCC | lld:pubmed |
| pubmed-article:7977167 | pubmed:author | pubmed-author:BlengioFF | lld:pubmed |
| pubmed-article:7977167 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7977167 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:7977167 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7977167 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7977167 | pubmed:pagination | 494-7 | lld:pubmed |
| pubmed-article:7977167 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:meshHeading | pubmed-meshheading:7977167-... | lld:pubmed |
| pubmed-article:7977167 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7977167 | pubmed:articleTitle | Intensified chemotherapy with granulocyte-monocyte colony stimulating factor protection in advanced, relapsed squamous cell carcinoma of the head and neck. A phase I study. | lld:pubmed |
| pubmed-article:7977167 | pubmed:affiliation | Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. | lld:pubmed |
| pubmed-article:7977167 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7977167 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7977167 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:7977167 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
